Revance Therapeutics (RVNC) Stock Chart & Stock Price History $3.66 -0.02 (-0.41%) As of 02:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Revance Therapeutics Stock Price Performance 5 Day Performance-0.68%1 Month Performance+18.28%3 Month Performance-30.91%6 Month Performance-8.85%Year-To-Date Performance+20.23%1 Year Performance-39.39% Receive RVNC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Revance Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address RVNC Stock Chart for Wednesday, January, 22, 2025 RVNC Chart by TradingView Revance Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/21/2025$3.68$3.67-0.27%$3.67$3.645.55 million shs$383.11 million01/20/2025$3.68$3.68$3.70$3.6011.24 million shs$384.16 million01/17/2025$3.27$3.68+12.54%$3.70$3.6011.24 million shs$384.16 million01/16/2025$3.28$3.27-0.30%$3.30$3.25657,968 shs$341.36 million01/15/2025$3.29$3.28-0.30%$3.38$3.28758,004 shs$342.40 million01/14/2025$3.29$3.29$3.31$3.26698,619 shs$343.44 million01/13/2025$3.25$3.29+1.23%$3.36$3.262.26 million shs$343.44 million01/10/2025$3.39$3.25-4.13%$3.34$3.234.43 million shs$339.27 million01/09/2025$3.39$3.39$3.50$3.352.37 million shs$353.88 million01/08/2025$3.41$3.39-0.59%$3.50$3.352.37 million shs$353.88 million Get the Latest News and Ratings for RVNC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Revance Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/07/2025$3.47$3.41-1.73%$3.51$3.382.30 million shs$355.97 million01/06/2025$3.09$3.47+12.30%$3.61$3.4613.02 million shs$362.23 million01/03/2025$3.06$3.09+0.98%$3.09$3.051.27 million shs$322.57 million01/02/2025$3.04$3.06+0.66%$3.08$3.033.29 million shs$319.43 million01/01/2025$3.04$3.04$3.07$3.031.38 million shs$317.35 million12/31/2024$3.06$3.04-0.65%$3.07$3.031.38 million shs$317.35 million12/30/2024$3.06$3.06$3.08$3.061.36 million shs$319.43 million12/27/2024$3.08$3.06-0.65%$3.08$3.061.16 million shs$319.43 million12/26/2024$3.08$3.08$3.08$3.07698,922 shs$321.52 million12/25/2024$3.08$3.08$3.08$3.07407,565 shs$321.52 million12/24/2024$3.07$3.08+0.33%$3.08$3.07407,565 shs$321.52 million12/23/2024$3.09$3.07-0.65%$3.09$3.061.26 million shs$320.48 million Related Companies ARDX Stock Chart NRIX Stock Chart KNSA Stock Chart RCUS Stock Chart MRVI Stock Chart OCUL Stock Chart ARVN Stock Chart CALT Stock Chart DAWN Stock Chart PRAX Stock Chart Receive RVNC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Revance Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RVNC) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revance Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revance Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RVNC Stock Alerts